Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hawkins

Showing results (351-360 of 580) with videos related to

Pageof 58
Sort By:
Plos One|May 18, 2018
Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1Nicola J Borthwick, Thirusha Lane, Nathifa Moyo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Solid organ transplantation in AL amyloidosisP T Sattianayagam, S D J Gibbs, J H Pinney, et al.
Kidney International|July 1, 1996
Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatologyS Y Tan, A Irish, C G Winearls, et al.
Journal of the American College of Cardiology|April 6, 2019
High Prevalence of Intracardiac Thrombi in Cardiac AmyloidosisAna Martinez-Naharro, Esther Gonzalez-Lopez, Andrej Corovic, et al.
Nature|April 8, 1993
Human lysozyme gene mutations cause hereditary systemic amyloidosisM B Pepys, P N Hawkins, D R Booth, et al.
Scientific Reports|March 17, 2017
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channelGuglielmo Verona, P Patrizia Mangione, Sara Raimondi, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Leukemia|January 6, 2022
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) AmyloidosisSriram Ravichandran, Steven Law, Shameem Mahmood, et al.
American Journal of Hematology|September 11, 2022
Long-term outcomes in light chain deposition disease-analysis of a UK cohortSriram Ravichandran, Steven Law, Shameem Mahmood, et al.
Haematologica|January 16, 2025
Ethnicity in systemic AL amyloidosis may impact risk stratificationJahanzaib Khwaja, Sriram Ravichandran, Oliver Cohen, et al.
Pageof 58

Showing results (351-360 of 580) with videos related to

Sort By:
Pageof 58
Plos One|May 18, 2018
Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1Nicola J Borthwick, Thirusha Lane, Nathifa Moyo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Solid organ transplantation in AL amyloidosisP T Sattianayagam, S D J Gibbs, J H Pinney, et al.
Kidney International|July 1, 1996
Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatologyS Y Tan, A Irish, C G Winearls, et al.
Journal of the American College of Cardiology|April 6, 2019
High Prevalence of Intracardiac Thrombi in Cardiac AmyloidosisAna Martinez-Naharro, Esther Gonzalez-Lopez, Andrej Corovic, et al.
Nature|April 8, 1993
Human lysozyme gene mutations cause hereditary systemic amyloidosisM B Pepys, P N Hawkins, D R Booth, et al.
Scientific Reports|March 17, 2017
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channelGuglielmo Verona, P Patrizia Mangione, Sara Raimondi, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Leukemia|January 6, 2022
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) AmyloidosisSriram Ravichandran, Steven Law, Shameem Mahmood, et al.
American Journal of Hematology|September 11, 2022
Long-term outcomes in light chain deposition disease-analysis of a UK cohortSriram Ravichandran, Steven Law, Shameem Mahmood, et al.
Haematologica|January 16, 2025
Ethnicity in systemic AL amyloidosis may impact risk stratificationJahanzaib Khwaja, Sriram Ravichandran, Oliver Cohen, et al.
Pageof 58